[MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
Year: 1994
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: T Seguchi, E Nakano, T Miki, M Kondoh, K Nishimura, N Nakamura, A Okuyama
Institution: Osaka University Hospital
Language: Japanese
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2417697013